Company
Claya
Claya publishes compounded semaglutide, compounded tirzepatide, oral semaglutide and brand tirzepatide, from $149 to $1,399 a month.
- 4 programs
- 4 molecules
- 4 readings
Read from claya.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Claya
We earn nothing from this link. Claya has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · ◯ $149 advertised · Homepage banner price
first month, including the required fees on record · ◯ $199 advertised · Homepage Tirzepatide Plan
first month, including the required fees on record · ◯ $279 advertised · Semaglutide Tablets
first month, including the required fees on record · ◯ $1,399 advertised · Mounjaro® Pen
Terms
| Membership | Required, $59 per month. Claya membership starts at $59 per month. |
|---|---|
| States | All 50 states |
Not yet checked: pharmacy and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Two different price schedules appear for the same products: the homepage banner lists Semaglutide 'as low as $149 /mo' and Tirzepatide 'Starting at $199 a month', while the dedicated Semaglutide product page lists 'As low as $179 /mo' and describes prescription medication as one of the included items at that price. Separately, the weight-loss FAQ states 'Claya membership starts at $59 per month' and explicitly 'your medication is not included in the membership fee' -- which membership figure relates to the $179/$149/$199 product prices is not stated anywhere in the fetched text, so the $59 figure is recorded only under `membership` and the product-page/homepage figures are recorded as `prices`. Claya explicitly does not accept insurance ('Claya does not accept commercial health insurance plans... you are obtaining products and services on a cash-pay basis'), so all prices above are cash prices. States: the blanket 'all fifty states' claim is qualified by a Louisiana carve-out specific to compounded GLP-1s ('due to applicable laws of the State of Louisiana, our third-party partner pharmacies cannot provide compounded GLP-1 medications to residents of the State of Louisiana' -- paraphrased from terms-of-use, original has a typo 'PRTNER').
Before you act
Cite this
Treatment Registry. (2026). Claya: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/claya